Patents by Inventor Hong Ryul JUNG

Hong Ryul JUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF
    Publication number: 20240246940
    Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. The heteroaryl derivative of the present invention exhibits excellent inhibitory activity against HER2 and EGFR, and thus can be effectively used as a therapeutic agent for HER2- and/or EGFR-associated diseases.
    Type: Application
    Filed: April 8, 2022
    Publication date: July 25, 2024
    Inventors: Yi Kyung KO, Jin Hee PARK, Yeong Deok LEE, Hye Rim IM, Kyun Eun KIM, Dong Keun HWANG, Ah Reum HAN, Su Been NAM, Myung Hoe HEO, Eun Hwa KO, Hwan Geun CHOI, Sung Hwan KIM, Hong Ryul JUNG, Ji Hye YOO
  • HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF
    Publication number: 20240166640
    Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 23, 2024
    Applicant: Voronoi Inc.
    Inventors: Youn Ho LEE, Seon Ah Hwang, In Seob Shim, Hyeon Ho Jeon, Woo Mi Do, Hee Sun Ryu, Jung Beom Son, Nam Doo Kim, Sung Hwan Kim, Hong Ryul Jung, Young Yi Lee
  • HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF
    Publication number: 20240025888
    Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.
    Type: Application
    Filed: May 16, 2022
    Publication date: January 25, 2024
    Applicant: Voronoi Inc.
    Inventors: Youn Ho LEE, Seon Ah HWANG, In Seob SHIM, Hyeon Ho JEON, Woo Mi DO, Hee Sun RYU, Jung Beom SON, Nam Doo KIM, Sung Hwan KIM, Hong Ryul JUNG, Young Yi LEE
  • HETEROARYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT
    Publication number: 20230183243
    Abstract: The present invention relates to a heteroaryl derivative and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient, and a compound according to an aspect of the present invention, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof suppresses kinases, particularly, a TTK kinase, and thus can remarkably suppress the proliferation of cancer cells, and accordingly, can be effectively used as a pharmaceutical composition for the prevention or treatment of cancer.
    Type: Application
    Filed: March 13, 2020
    Publication date: June 15, 2023
    Inventors: U Bin KIM, Youn Ho LEE, Se In KANG, Ju Hee KANG, Seon An HWANG, Da Mi KIM, Seung Su KIM, Myung Ho JUNG, Hyun Kyung KIM, Hong Ryul JUNG, Yeon Sil KIM, Hye Jin JANG, Ji Eun CHOI, Sun Hwa LEE, Jung Beom SON, Nam Doo KIM